Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1962 1
1963 2
1964 3
1966 3
1968 6
1969 1
1970 6
1971 8
1972 5
1973 7
1974 9
1975 5
1976 6
1977 2
1978 7
1979 8
1980 10
1981 11
1982 13
1983 14
1984 10
1985 15
1986 17
1987 21
1988 16
1989 20
1990 19
1991 21
1992 21
1993 17
1994 14
1995 13
1996 9
1997 25
1998 28
1999 21
2000 36
2001 39
2002 37
2003 39
2004 35
2005 35
2006 37
2007 19
2008 30
2009 25
2010 39
2011 41
2012 58
2013 53
2014 63
2015 56
2016 64
2017 69
2018 81
2019 94
2020 104
2021 110
2022 128
2023 109
2024 89
2025 73

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,756 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population.
Casadei-Gardini A, Rimini M, Tada T, Suda G, Shimose S, Kudo M, Cheon J, Finkelmeier F, Lim HY, Rimassa L, Presa J, Masi G, Yoo C, Lonardi S, Tovoli F, Kumada T, Sakamoto N, Iwamoto H, Aoki T, Chon HJ, Himmelsbach V, Pressiani T, Montes M, Vivaldi C, Soldà C, Piscaglia F, Hiraoka A, Sho T, Niizeki T, Nishida N, Steup C, Iavarone M, Di Costanzo G, Marra F, Scartozzi M, Tamburini E, Cabibbo G, Foschi FG, Silletta M, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Ochi H, Yasuda S, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Shimada N, Kawata K, Tada F, Ohama H, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Imai M, Kosaka H, Naganuma A, Koizumi Y, Nakamura S, Kaibori M, Iijima H, Hiasa Y, Burgio V, Persano M, Della Corte A, Ratti F, De Cobelli F, Aldrighetti L, Cascinu S, Cucchetti A. Casadei-Gardini A, et al. Among authors: tada t. Eur J Cancer. 2023 Feb;180:9-20. doi: 10.1016/j.ejca.2022.11.017. Epub 2022 Nov 25. Eur J Cancer. 2023. PMID: 36527976 Clinical Trial.
Statin Discontinuation After Coronary Revascularization.
Yamamoto K, Morimoto T, Natsuaki M, Shiomi H, Ogita M, Tada T, Toyota T, Nakatsuma K, Ehara N, Yamaji K, Tazaki J, Toyofuku M, Yokomatsu T, Kadota K, Ando K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Yamamoto K, et al. Among authors: tada t. Am J Cardiol. 2023 Nov 15;207:479-489. doi: 10.1016/j.amjcard.2023.09.047. Epub 2023 Oct 3. Am J Cardiol. 2023. PMID: 37798170
MARCH8: the tie that binds to viruses.
Tada T, Zhang Y, Fujita H, Tokunaga K. Tada T, et al. FEBS J. 2022 Jul;289(13):3642-3654. doi: 10.1111/febs.16017. Epub 2021 May 31. FEBS J. 2022. PMID: 33993615 Free article. Review.
Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.
Kariyama K, Nouso K, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Wakuta A, Oonishi A, Kumada T, Kudo M, Group OBOTRPEFHRS, Group H. Kariyama K, et al. Among authors: tada t. Cancers (Basel). 2019 Feb 10;11(2):203. doi: 10.3390/cancers11020203. Cancers (Basel). 2019. PMID: 30744175 Free PMC article.
Xanthomatous Pleuritis Associated With Pancreaticopleural Fistula.
Nakashima K, Demura Y, Tada T, Akai M, Ishizuka T. Nakashima K, et al. Among authors: tada t. J Bronchology Interv Pulmonol. 2022 Apr 1;29(2):155-157. doi: 10.1097/LBR.0000000000000834. J Bronchology Interv Pulmonol. 2022. PMID: 34907976 Free PMC article. No abstract available.
Protocol of the IMPACT study: randomized, multicenter, phase 3 study evaluating the efficacy of immunotherapy (Atezolizumab) plus anti-VEGF therapy (Bevacizumab) in combination with transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma.
Kodama Y, Ueshima K, Moriguchi M, Inaba Y, Yamashita T, Iwamoto H, Ueno M, Ogasawara S, Kuzuya T, Kodama T, Sato Y, Tada T, Tsuchiya K, Nishiofuku H, Yamakado K, Sone M, Ikeda M, Takehara T, Hamano T, Kudo M. Kodama Y, et al. Among authors: tada t. BMC Cancer. 2025 Mar 11;25(1):434. doi: 10.1186/s12885-025-13648-5. BMC Cancer. 2025. PMID: 40069616 Free PMC article.
Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2.
Taniguchi T, Morimoto T, Takeji Y, Shirai S, Ando K, Tabata H, Yamamoto K, Murai R, Osakada K, Sakamoto H, Tada T, Murata K, Obayashi Y, Amano M, Kitai T, Izumi C, Toyofuku M, Kanamori N, Miyake M, Nakayama H, Izuhara M, Nagao K, Nakatsuma K, Furukawa Y, Inoko M, Kimura M, Ishii M, Usami S, Nakazeki F, Shirotani M, Inuzuka Y, Ono K, Minatoya K, Kimura T; CURRENT AS Registry-2 Investigators. Taniguchi T, et al. Among authors: tada t. JACC Cardiovasc Interv. 2025 Feb 24;18(4):471-487. doi: 10.1016/j.jcin.2024.09.044. Epub 2024 Dec 18. JACC Cardiovasc Interv. 2025. PMID: 39708011
Central mechanisms involved with catabolism.
Nandi J, Meguid MM, Inui A, Xu Y, Makarenko IG, Tada T, Chen C. Nandi J, et al. Among authors: tada t. Curr Opin Clin Nutr Metab Care. 2002 Jul;5(4):407-18. doi: 10.1097/00075197-200207000-00010. Curr Opin Clin Nutr Metab Care. 2002. PMID: 12107377 Review.
Neutrophil-Lymphocyte Ratio Predicts Overall Survival in Patients With HCC Treated With Durvalumab Plus Tremelimumab.
Matono T, Tada T, Kumada T, Hiraoka A, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Nishikawa H, Tanaka K, Tsuji K, Ishikawa T, Tajiri K, Koshiyama Y, Toyoda H, Ogawa C, Hatanaka T, Kakizaki S, Kawata K, Ohama H, Tada F, Nouso K, Morishita A, Tsutsui A, Nagano T, Itokawa N, Okubo T, Arai T, Nishimura T, Imai M, Kosaka H, Naganuma A, Aoki T, Kuroda H, Yata Y, Tamai H, Matsuura T, Komatsu S, Ueda Y, Nakamura Y, Yoshida O, Nakamura S, Enomoto H, Kaibori M, Fukumoto T, Hiasa Y, Kudo M; Real‐life Practice Experts for HCC (RELPEC) Study Group and the Hepatocellular Carcinoma Experts from 48 clinics in Japan (HCC 48) Group. Matono T, et al. Among authors: tada t. Hepatol Res. 2025 Sep;55(9):1285-1295. doi: 10.1111/hepr.14224. Epub 2025 Jun 14. Hepatol Res. 2025. PMID: 40515751
1,756 results